Our Services
Medical Information
Helpful Resources
Published on: 5/22/2026
Treatment options for AERD combine inhaled steroids, nasal sprays and leukotriene modifiers with advanced approaches such as aspirin desensitization, biologic therapies targeting interleukin pathways, novel leukotriene inhibitors and endoscopic sinus surgery.
There are several factors to consider when choosing which path may be best. See below for important details on monitoring, benefits, risks and emerging research that could impact your next steps.
Aspirin-Exacerbated Respiratory Disease (AERD), also known as Samter triad, affects thousands of patients worldwide. This condition combines asthma, nasal polyps, and sensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin. If you're seeking treatment options for AERD Samter triad patient care, you've come to the right place. Below we'll explore both established and emerging therapies, so you can work with your healthcare team to find the best path forward.
AERD arises when the balance of pro-inflammatory and anti-inflammatory mediators in the airways is disrupted. Key features include:
Understanding this triad helps explain why standard asthma or allergy therapies may not fully control symptoms in AERD patients.
Inhaled Corticosteroids + Bronchodilators
• Reduce airway inflammation
• Improve daily asthma control
Nasal Corticosteroid Sprays
• Shrink nasal polyps
• Decrease congestion and runny nose
Leukotriene Modifiers (e.g., Montelukast, Zafirlukast)
• Block inflammatory chemicals called leukotrienes
• Offer modest relief, especially when added to inhaled steroids
Short-Course Oral Steroids
• Used for severe asthma flare-ups or polyp regrowth
• Effective but long-term use carries risk of bone thinning, weight gain, and other side effects
While these approaches help many, some AERD patients continue to experience symptoms or require frequent steroid bursts. That's where advanced science paths come in.
Aspirin desensitization is a cornerstone for many AERD patients. It involves:
Benefits:
Considerations:
Biologics target specific molecules in the inflammatory cascade. They are delivered via injection or infusion and include:
Anti-IL-5 Therapies (Mepolizumab, Reslizumab)
• Reduce eosinophils, key inflammatory cells in AERD
• Can lessen asthma exacerbations and nasal polyp size
Anti-IL-5 Receptor Therapy (Benralizumab)
• Destroys eosinophils directly
• Demonstrates improved lung function and reduced polyp burden
Anti-IL-4 Receptor Therapy (Dupilumab)
• Blocks IL-4 and IL-13 pathways
• Shown to decrease polyp size and improve nasal airflow
What to know:
Researchers are developing next-generation leukotriene inhibitors that:
While still under clinical study, these agents may one day enhance symptom control beyond current leukotriene modifiers.
Surgery isn't a cure, but ESS can:
Post-surgery care often includes nasal washes and topical steroids to prolong benefits. For many AERD patients, ESS combined with medical therapy leads to better outcomes.
Alongside medical treatments, practical steps can ease daily life:
• Dietary Adjustments
– Some patients find relief by reducing foods high in salicylates (e.g., tomatoes, berries, nuts)
– A balanced anti-inflammatory diet (rich in omega-3s, low in processed foods) may help
• Allergen and Irritant Avoidance
– Minimize exposure to tobacco smoke, strong perfumes, and indoor pollutants
• Regular Exercise
– Improves lung function and overall well-being
– Choose low-impact activities like walking or swimming
• Stress Management
– Techniques like mindfulness, yoga, or counseling can reduce asthma flare triggers
Science continues to push boundaries in AERD care:
Gene Therapy
Investigational approaches aim to correct underlying inflammatory gene expression.
Microbiome Modulation
Studies are exploring whether adjusting nasal or gut bacteria can reduce inflammation.
Small-Molecule Drugs
Targeting intracellular signaling pathways promises more precise control of airway inflammation.
While these are not yet standard care, they highlight the rapid pace of discovery.
If you're struggling with persistent asthma symptoms, recurrent sinus infections, or nasal polyp regrowth despite standard treatments, discuss advanced options with your specialist. Before your appointment, you can get personalized insights by using a Medically approved LLM Symptom Checker Chat Bot to help identify which symptoms might warrant immediate attention and prepare informed questions for your healthcare provider.
Always speak to a healthcare professional before making changes to your treatment plan. If you experience severe breathing difficulties, high fever, or other alarming symptoms, seek immediate medical attention.
(References)
* Stevens WW, Peters AT, Laidlaw TM. Biologics in Aspirin-Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2369-2376. doi: 10.1016/j.jaip.2022.08.016. Epub 2022 Aug 23. PMID: 36024982; PMCID: PMC9630985.
* Palumbo ML, Laidlaw TM, Lee JJ. Aspirin-Exacerbated Respiratory Disease: Current and Emerging Treatment Options. Front Med (Lausanne). 2024 Jan 15;10:1309831. doi: 10.3389/fmed.2023.1309831. PMID: 38218151; PMCID: PMC10822180.
* Palumbo ML, Peters AT, Laidlaw TM. Targeted Therapies for Aspirin-Exacerbated Respiratory Disease. Curr Allergy Asthma Rep. 2022 Jun;22(6):265-274. doi: 10.1007/s11882-022-01041-x. Epub 2022 May 31. PMID: 35650170; PMCID: PMC9154941.
* Stevens WW, Laidlaw TM. Biologics for the Treatment of Aspirin-Exacerbated Respiratory Disease. Immunol Allergy Clin North Am. 2021 May;41(2):339-354. doi: 10.1016/j.iac.2021.01.002. Epub 2021 Mar 26. PMID: 33898144.
* Laidlaw TM, Peters AT. Precision Medicine for Aspirin-Exacerbated Respiratory Disease. Clin Rev Allergy Immunol. 2021 Feb;60(1):153-162. doi: 10.1007/s12016-020-08819-2. PMID: 32973418; PMCID: PMC7833036.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.